June 8th 1pm EDT Webinar Hosted by CEO David Regan & CSO Len Pagliaro PhD

Live investor webinar hosted by David Regan, CEO and Len Pagliaro PhD, CSO in which they discuss the development of Sona’s pre-clinical Targeted Hyperthermia Therapy, which leverages Sona’s biocompatible Gold Nanorods.